SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-014909
Filing Date
2019-05-02
Accepted
2019-05-01 18:01:18
Documents
56
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acad-10q_20190331.htm 10-Q 1537349
2 EX-31.1 acad-ex311_10.htm EX-31.1 9484
3 EX-31.2 acad-ex312_9.htm EX-31.2 9218
4 EX-32.1 acad-ex321_7.htm EX-32.1 6335
5 EX-32.2 acad-ex322_8.htm EX-32.2 6385
  Complete submission text file 0001564590-19-014909.txt   5251386

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acad-20190331.xml EX-101.INS 1120547
7 XBRL TAXONOMY EXTENSION SCHEMA acad-20190331.xsd EX-101.SCH 36739
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20190331_cal.xml EX-101.CAL 55786
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20190331_def.xml EX-101.DEF 92788
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20190331_lab.xml EX-101.LAB 297654
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20190331_pre.xml EX-101.PRE 216242
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 19789029
SIC: 2834 Pharmaceutical Preparations